Literature DB >> 6612753

Bile acids in patients suffering from colorectal carcinoma--a pilot study.

W J Kurtz, U Leuschner.   

Abstract

Bile acids are increasingly discussed in the genesis of colorectal carcinoma. In a pilot study we analysed bile acids in tumor tissue, tumor-free mucosa, serum, and feces of 6 patients with rectal and 3 patients with colonic carcinoma. 5 patients dead from nongastroenterological diseases and two operated on for benign colonic stenosis served as controls for colorectal mucosa, 16 healthy persons as controls for feces and serum. Bile acids and their sulphates were determined after differential solvolysis by gas-liquid chromatography on QF-1 columns. Serum lithocholic acid was significantly (p less than 0, 05) elevated in all carcinoma patients. The feces showed a trend towards increased secondary bile acids. Tumor-free mucosa of patients with rectal carcinoma showed elevated unsulphated bile acids, sulphated lithocholic acid (p less than 0, 05) and sulphated chenodeoxycholic acid (p less than 0, 025) were significantly decreased. In rectal carcinoma tissue total bile acids were elevated, cholic acid (p less than 0, 01) and sulphated lithocholic acid decreased (p less than 0, 05). In nonaffected colonic mucosa of patients with colonic carcinoma total bile acids were decreased, in colonic carcinoma tissue only traces of bile acids were found. Whether these changes are causes or rather consequences of colorectal tumors--e.g. tumor-induced stasis in the gut--and whether they may be useful for diagnosis remains to be elucidated in further studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6612753

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  4 in total

1.  The role of bile acids in colonic carcinogenesis.

Authors:  N Breuer; H Goebell
Journal:  Klin Wochenschr       Date:  1985-02-04

2.  Molecular docking and machine learning analysis of Abemaciclib in colon cancer.

Authors:  Jose Liñares-Blanco; Cristian R Munteanu; Alejandro Pazos; Carlos Fernandez-Lozano
Journal:  BMC Mol Cell Biol       Date:  2020-07-08

Review 3.  Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.

Authors:  Miljana Nenkov; Yunxia Ma; Nikolaus Gaßler; Yuan Chen
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

4.  High expression of FABP4 and FABP6 in patients with colorectal cancer.

Authors:  Yaqin Zhang; Xiaotong Zhao; Lili Deng; Xueting Li; Ganbiao Wang; Yongxing Li; Mingwei Chen
Journal:  World J Surg Oncol       Date:  2019-10-24       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.